NASDAQ · PIII
P3 Health Partners Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for PIII: Nov 09, 2026
P3 Health Partners Inc. Class A Common Stock is expected to report earnings on 11/09/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. The reported EPS for the same quarter last year was $-9.67.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
The Motley Fool · RTTNews · MarketBeat · Fintel- The Motley Fool · Aug 17, 5:14 PM EDTP3 Health Partners (PIII) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Aug 11, 12:34 AM EDTP3 Health Partners Swings To Q2 Profit, Lifts 2026 Guidance; Stock Up(RTTNews) – P3 Health Partners Inc. (PIII) reported financial results for the second quarter ended June 30, 2026, showing revenue growth and a swing to profitability compared with the prior year. The Henderson, Nevada-based population health management company operates through ph
- MarketBeat · Aug 10, 8:04 PM EDTP3 Health Partners Q2 Earnings Call HighlightsAfter Soaring 182% Is Time To Ring The Register In P3 Health?P3 Health Partners (NASDAQ:PIII) reported second-quarter adjusted EBITDA of $54 million and raised its full-year 2026 outlook, while noting that the quarterly result included $45 million of favorable payer settlements a
- RTTNews · May 28, 4:11 AM EDTTop Biotech Gainers: QTTB Has A Good Hair Day, GH Wins ACS Recommendation, Ebola Lifts SNGX, NNVX(RTTNews) – Today's Top Gainers list features Q32 Bio, which announced a $55 million private placement financing; Soligenix, which is exploring the suitability of its ThermoVax platform to fight the Bundibugyo strain of Ebola virus; P3 Health Partners, which recently reported str
- RTTNews · May 21, 10:34 PM EDTBiotech Stock Gainers: CODX Extends Rally, SBFM Surges, GOVX Ebola Strategy, RGNX Awaits Catalysts(RTTNews) – Today's gainers include CODX, which rallied for the third straight day; Akari, on breakthrough clinical data in pancreatic cancer; Sunshine, following regulatory approval for its generic Amoxicillin; GOVX, amid Ebola concerns; and RGNX, on upcoming clinical trial mile
- The Motley Fool · May 15, 12:52 PM EDTP3 Health (PIII) Q4 2025 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- The Motley Fool · May 15, 12:48 PM EDTP3 Health (PIII) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · May 15, 1:48 AM EDTP3 Health Partners Posts Q1 2026 Profit, Raises Full-Year Guidance; Stock Up(RTTNews) – P3 Health Partners Inc. (PIII), a physician-led population health management company, reported first-quarter 2026 results and raised its full-year adjusted EBITDA outlook, citing stronger-than-expected performance.
- Fintel · Nov 17, 7:05 PM ESTLake Street Maintains P3 Health Partners (PIII) Buy RecommendationFintel reports that on November 17, 2025, Lake Street maintained coverage of P3 Health Partners (NasdaqCM:PIII) with a Buy recommendation. Analyst Price Forecast Suggests 121.74% Upside
- BNK Invest · Nov 4, 10:09 AM ESTImplied ONEQ Analyst Target Price: $104Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself.
- The Motley Fool · Aug 14, 5:30 PM EDTP3 Health (PIII) Q2 2025 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 14, 5:15 PM EDTP3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue EstimatesP3 Health Partners (PIII) delivered earnings and revenue surprises of -89.36% and -2.03%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for P3 Health Partners Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.